Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Daunoxome |
Trade Name | |
Synonyms | Liposomal daunorubicin citrate |
Drug Descriptions |
Daunoxome is a liposomal formulation of the anthracyline, daunorubicin and is FDA approved for HIV-associated Kaposi’s sarcoma (FDA.gov). |
DrugClasses | Chemotherapy - Anthracycline 13 |
CAS Registry Number | NA |
NCIT ID | C2213 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cytarabine + Daunoxome | Cytarabine Daunoxome | 0 | 2 |
Cytarabine + Daunoxome + Fludarabine | Cytarabine Daunoxome Fludarabine | 0 | 1 |
Cytarabine + Daunoxome + Fludarabine + Methotrexate | Cytarabine Daunoxome Fludarabine Methotrexate | 0 | 1 |
Daunoxome | Daunoxome | 0 | 1 |
Daunoxome + Pembrolizumab | Daunoxome Pembrolizumab | 0 | 0 |